Votrient 200 MG Tablet contains Pazopanib 200mg, providing a lower-dose option for dose adjustment or patients requiring titration during targeted therapy for renal cell carcinoma or soft tissue sarcoma.

How It Works: Pazopanib inhibits multiple VEGFR and PDGFR tyrosine kinases simultaneously, cutting off blood supply to tumors and blocking intrinsic cancer cell survival mechanisms.

Common Uses: Dose-adjusted treatment of advanced renal cell carcinoma and soft tissue sarcoma, or as prescribed within individualized targeted therapy regimens.

Administration: Take once daily on an empty stomach, at least 1 hour before or 2 hours after eating. Swallow tablets whole with water.

Storage: Store below 25°C away from moisture and direct light. Keep in original packaging out of children's reach.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.